Skip to main content
OpenTrials
Completed

NCT Number: NCT04365530

Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City

The ongoing Coronavirus (Covid-19) pandemic is causing a major global health crisis and is shaking up hospital organizations. To date, the recognized risk factors for severe forms of Covid-19 infection are elderly patients (> 70 years), obese patients, patients with chronic renal or respiratory pathologies, cardiovascular history (stroke or coronary artery disease), chronic respiratory conditions, high blood pressure, diabetes, and cancer. Covid-19 is manifested by a risk of acute respiratory distress syndrome requiring management by invasive ventilation. The lethality of this infection is around 4% in the current data.

Drastic precautionary measures for the transmission of the virus, as well as the provision of critical care beds by canceling any scheduled non-urgent intervention or consultation, have shaken up the hospital organization.

In this context, it is essential to have forward-looking data in real time to adjust the care offer and better understand the impact of Covid-19 on the patient populations treated.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Marie Lannelongue, Le Plessis-Robinson, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient (of all ages) with symptoms compatible with infection by Covid-19 treated at the GHPSJ or in one of the establishments in the Paris Plaisance hospital city.

Exclusion criteria

  • Asymptomatic patient
  • Patient objecting to the use of their data

Treatment and study plan

Primary outcomes

  1. Clinical consequences of a Covid-19 infection in the care population

    Time frame: Year 2

    This outcome measures the clinical consequences of a Covid-19 infection in the care population.

Secondary outcomes

  1. Risk factors at M6

    Time frame: Month 6

    This outcome evaluates the risk factors of COVID-19 at month 6

  2. Risk factors at year 1

    Time frame: Year 1

    This outcome evaluates the risk factors of COVID-19.

  3. Risk factors at year 2

    Time frame: Year 2

    This outcome evaluates the risk factors of COVID-19.

  4. Impact of hospital reorganization on medical care at M6

    Time frame: Month 6

    This outcome evaluates the impact of hospital reorganization on medical care at month 6.

  5. Impact of hospital reorganization on medical care at Year 1

    Time frame: Year 1

    This outcome evaluates the impact of hospital reorganization on medical care at year 1.

  6. Impact of hospital reorganization on medical care at Year 2

    Time frame: Year 2

    This outcome evaluates the impact of hospital reorganization on medical care at year 2.

Sponsors and collaborators

Lead sponsor

Fondation Hôpital Saint-Joseph

Other

Registry information

Acronym: COVIDGHPSJCite

Important dates

Study start
2020
Primary completion
2022
Study completion
2023
First posted
Apr 28, 2020
Registry last updated
Mar 7, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.